Moors & Cabot’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,800
| Closed | -$203K | – | 842 |
|
|
2022
Q1 | $203K | Hold |
2,800
| – | – | 0.01% | 772 |
|
|
2021
Q4 | $331K | Buy |
2,800
+800
| +40% | +$94.6K | 0.02% | 591 |
|
|
2021
Q3 | $267K | Hold |
2,000
| – | – | 0.02% | 642 |
|
|
2021
Q2 | $324K | Buy |
+2,000
| New | +$324K | 0.02% | 543 |
|
|
2019
Q2 | – | Sell |
-10,550
| Closed | -$184K | – | 563 |
|
|
2019
Q1 | $184K | Buy |
+10,550
| New | +$184K | 0.03% | 491 |
|
|
2018
Q4 | – | Sell |
-9,700
| Closed | -$275K | – | 550 |
|
|
2018
Q3 | $275K | Sell |
9,700
-500
| -5% | -$14.2K | 0.03% | 442 |
|
|
2018
Q2 | $279K | Buy |
+10,200
| New | +$279K | 0.04% | 431 |
|